ExodusPoint Capital Management’s Royalty Pharma RPRX Stock Holding History

ExodusPoint Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-123,562	Closed	-$5.93M	–	1985
2026 Q1	$5.93M	Buy	+123,562	New	+$5.41M	0.05%	383
2025 Q3	–	Sell	-246,638	Closed	-$8.89M	–	1943
2025 Q2	$8.89M	Buy	+246,638	New	+$8.17M	0.08%	266
2025 Q1	–	Sell	-143,601	Closed	-$3.66M	–	1928
2024 Q4	$3.66M	Buy	+143,601	New	+$3.81M	0.03%	530
2024 Q1	–	Sell	-70,607	Closed	-$1.98M	–	1902
2023 Q4	$1.98M	Sell	70,607 -35,937	-34%	-$988K	0.01%	579
2023 Q3	$2.89M	Sell	106,544 -378,654	-78%	-$11.2M	0.03%	553
2023 Q2	$14.9M	Buy	485,198 +287,283	+145%	+$9.73M	0.12%	163
2023 Q1	$7.13M	Buy	197,915 +38,951	+25%	+$1.44M	0.06%	391
2022 Q4	$6.28M	Buy	158,964 +151,917	+2,156%	+$6.34M	0.09%	296
2022 Q3	$283K	Buy	+7,047	New	+$301K	﹤0.01%	1539
2022 Q2	–	Sell	-93,492	Closed	-$3.64M	–	2374
2022 Q1	$3.64M	Buy	+93,492	New	+$3.67M	0.05%	505
2021 Q3	–	Sell	-105,724	Closed	-$4.33M	–	2554
2021 Q2	$4.33M	Buy	105,724 +89,128	+537%	+$3.79M	0.05%	403
2021 Q1	$724K	Buy	+16,596	New	+$787K	0.01%	1118
2020 Q4	–	Sell	-234,190	Closed	-$9.85M	–	2326
2020 Q3	$9.85M	Buy	234,190 +211,536	+934%	+$9.08M	0.2%	93
2020 Q2	$1.1M	Buy	+22,654	New	+$1.12M	0.03%	694

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ExodusPoint Capital Management's RPRX Position: Q2 2026 in Review

ExodusPoint Capital Management sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 123,562 shares — an estimated $5.93M sold.

ExodusPoint Capital Management first reported a position in RPRX in Q2 2020 and held it in 14 quarters. The position peaked at $14.9M in Q2 2023. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

ExodusPoint Capital Management reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 123,562 Royalty Pharma shares in Q2 2026, an estimated $5.93M.
ExodusPoint Capital Management first reported a position in Royalty Pharma in Q2 2020 and held it in 14 quarters.
ExodusPoint Capital Management's Royalty Pharma position peaked at $14.9M in Q2 2023.
641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.